MedDataX Logo

Bioactive Milk Peptides and Blood Pressure

NCT ID: NCT01031485

Last Updated: 2014-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2010-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the effects of bioactive milk peptides on blood pressure in mildly hypertensive subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stage 1 Hypertension

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

hypertension blood pressure milk peptides bioactive peptides randomized controlled trial

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

DOUBLE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Spread with milk peptides and plant sterols

Group Type ACTIVE_COMPARATOR

Milk peptides and plant sterols

Intervention Type DIETARY_SUPPLEMENT

Standard spread

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Milk peptides and plant sterols

Intervention Type DIETARY_SUPPLEMENT

Placebo

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 30-60 years
* systolic blood pressure 140-160 mmHg and diastolic blood pressure 90-99 mmHg in office measurement
* apparently healthy

Exclusion Criteria

* antihypertensive and lipid-lowering drugs
* unstable coronary artery disease, diabetes, malignant diseases, secondary hypertension
* BMI \> 32 kg/m2
* milk allergy
* smoking
* alcohol abuse
* pregnancy, lactation
* simultaneous participation in other clinical trial
Minimum Eligible Age

30 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Helsinki

OTHER

Sponsor Role collaborator

Valio Ltd

INDUSTRY

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Valio Ltd

Helsinki, Uusimaa, Finland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Finland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Valio-70

Identifier Type: -

Identifier Source: org_study_id